Save Article

Drugmakers Raise Prices on Hundreds of Medicines

New analysis shows Allergan setting the pace with increases of nearly 10% on more than two dozen products

By

Jared S. Hopkins

Updated Jan. 1, 2019 9:13 p.m. ET

Pharmaceutical companies are ringing in the new year by raising the price of hundreds of drugs, with Allergan PLC setting the pace with increases of nearly 10% on more than two dozen products, according to a new analysis.

Many companies’ increases are relatively modest this year, amid growing public and political pressure on the industry over prices. Yet a few are particularly high, including on some generics, the cheaper alternative to branded accounting for nine out of 10 prescriptions filled in the U.S. Overall, price increases,...

RELATED VIDEO

High Insulin Prices Drive Diabetics to Take Extreme Measures

The price of insulin has skyrocketed over the last few decades, making it increasingly difficult for diabetics to afford. WSJ’s Jason Bellini takes a look at some of the unconventional steps Americans are taking to access the lifesaving drug.